Abstract: Aspects described herein relate to securely performing cross-boundary backup operations. A service of a computing resource service provider may enable backup operations between a source account and a destination account of an organization based at least in part on a security policy allowing such operations.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula I wherein B signifies a 9-purinyl residue B1 of formula or a 1-pyrimidyl residue B2 of formula wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof; for the treatment of diseases mediated by the Hepatitis C Virus (HCV), for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof which inhibit HCV polymerase and are useful for treating a patient suffering from a HCV infection and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula Ia wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof and to pharmaceutical compositions containing such compounds.

Abstract: The present invention relates to the use of nucleoside derivatives of formula I wherein B signifies a 9-purinyl residue B1 of formula or a 1-pyrimidyl residue B2 of formula wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof; for the treatment of diseases mediated by the Hepatitis C Virus (HCV), for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.

Abstract: A system and method for managing data in a computer system. A backup server is configured to harvest data indicative of logical relationships among data entries in a backup data set. The harvested data and backup data set are stored on a backup medium. Catalog entries are created for both the backup data set and the harvested data. The computer system allows a user to browse the backup catalog, including the logical structure of the content of a particular backup data set. The user may select particular items for restoration from the catalog. In response, the server restores the backup data set and harvested data to a temporary location, identifies data in the harvested data which corresponds to the user's selections, searches the backup data set for the selected items, and initiates restoration of the selected items.

Abstract: A method and mechanism for performing backup and restore operations in a computing system. A computing system includes a first agent on a first host, a second agent on a second host, a plurality of data sources, and a backup server. The backup server sends a first request to the first agent for a logical backup data set that is distributed on the plurality of data sources. The first agent, in response to the first request, conveys a first portion of the logical backup data set from a first data source to the backup server and sends a second request for backup data to the second agent. The second agent conveys a second portion of the logical backup data set from a second data source to the first agent in response to the second request.

Abstract: The present invention relates to the use of nucleoside derivatives of formula I 1

Abstract: The present invention relates to the use of nucleoside derivatives of formula I wherein B signifies a 9-purinyl residue B1 of formula or a 1-pyrimidyl residue B2 of formula wherein the symbols are as defined in the specification, and of pharmaceutically acceptable salts thereof; for the treatment of diseases mediated by the Hepatitis C Virus (HCV), for the preparation of a medicament for such treatment and to pharmaceutical compositions containing such compounds.

Abstract: Method for producing elastic tapes from a fabric web having at least partially synthetic fibers or filaments, especially a nonwoven fabric web, for use in the garment industry, one or a plurality of industrially produced webs (1, 2; 16) being laid on top of one another and at their open edges (3, 4; 5, 6; 18, 19) being joined to one another and a tube (11) being formed; and wall (21) of the tube (11) is cut open slantwise, so that a new, more elastic fabric web (22) is created, which is cut to tapes (25) in the longitudinal direction (26).

Abstract: The present invention relates to the use of nucleoside derivatives of formula I 1

Abstract: The present invention comprises nucleoside derivatives for use in the treatment or prophylaxis of hepatitis C virus infections. In particular, the present invention discloses the novel use of known 2′-deoxy-2′-fluoro nucleoside derivatives as inhibitors of hepatitis C virus (HCV) RNA replication and pharmaceutical compositions of such compounds. The compounds of this invention have potential use as therapeutic agents for the treatment of HCV infections.

Abstract: The present invention comprises nucleoside derivatives for use in the treatment or prophylaxis of hepatitis C virus infections. In particular, the present invention discloses the novel use of known 2′-deoxy-2′-fluoro nucleoside derivatives as inhibitors of hepatitis C virus (HCV) RNA replication and pharmaceutical compositions of such compounds. The compounds of this invention have potential use as therapeutic agents for the treatment of HCV infections.

Abstract: A computer network having a number of workstations running disparate operating systems and a file server having a tape drive for backup and restore of data on the network. The file server runs a generic remote file system (GRFS) and workstations run GRFS agent programs which allow the GRFS file system to access data within a workstation having a given GRFS agent program. The GRFS file system interfaces with each GRFS agent program via a command/response paradigm, with the messages being structured to support the disparate operating systems for backup and restore, to allow data to be interchanged between the disparate operating systems, and to allow independent multiple users of the network to request simultaneously backup or restore.